Stock 2230 SAUDI CHEMICAL HOLDING COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Saudi Chemical Holding Company

Equities

2230

SA0007879402

Drug Retailers

End-of-day quote Saudi Arabian S.E.
Other stock markets
 06:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
7.77 SAR -5.36% Intraday chart for Saudi Chemical Holding Company +0.39% +79.86%
Apr. 15 Saudi Shares Close in Green; Wider Middle East War Concerns Intensify MT
Mar. 17 Saudi Chemical Holding Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,964 2,022 2,947 2,858 2,234 3,643
Enterprise Value (EV) 1 3,074 3,362 4,526 4,663 3,650 4,735
P/E ratio 17.1 x 61.5 x 39.8 x 41.1 x 27.9 x 19.9 x
Yield - - 1.43% 1.47% 1.89% 1.16%
Capitalization / Revenue 0.67 x 0.69 x 0.89 x 0.84 x 0.6 x 0.75 x
EV / Revenue 1.04 x 1.14 x 1.37 x 1.37 x 0.99 x 0.98 x
EV / EBITDA 14.5 x 21.2 x 23.6 x 25.1 x 16.8 x 13.3 x
EV / FCF -16.1 x -15.4 x -20.3 x -33.5 x 8.22 x 15.3 x
FCF Yield -6.21% -6.51% -4.92% -2.99% 12.2% 6.55%
Price to Book 1.29 x 1.24 x 1.81 x 1.77 x 1.35 x 2.02 x
Nbr of stocks (in thousands) 843,200 843,200 843,200 843,200 843,200 843,200
Reference price 2 2.329 2.398 3.495 3.390 2.650 4.320
Announcement Date 3/31/19 3/31/20 3/31/21 3/24/22 3/23/23 3/17/24
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,949 2,949 3,306 3,411 3,696 4,855
EBITDA 1 212.7 158.9 191.6 185.4 217.2 356.7
EBIT 1 181.8 122 148.4 142.9 176.2 315.1
Operating Margin 6.17% 4.14% 4.49% 4.19% 4.77% 6.49%
Earnings before Tax (EBT) 1 142.9 66.24 108.2 106.8 114.2 217.8
Net income 1 114.8 32.88 74.03 69.57 80.22 182.9
Net margin 3.89% 1.11% 2.24% 2.04% 2.17% 3.77%
EPS 2 0.1362 0.0390 0.0878 0.0825 0.0951 0.2169
Free Cash Flow 1 -191 -219 -222.6 -139.3 443.8 310.2
FCF margin -6.48% -7.43% -6.73% -4.08% 12.01% 6.39%
FCF Conversion (EBITDA) - - - - 204.31% 86.94%
FCF Conversion (Net income) - - - - 553.26% 169.59%
Dividend per Share - - 0.0500 0.0500 0.0500 0.0500
Announcement Date 3/31/19 3/31/20 3/31/21 3/24/22 3/23/23 3/17/24
1SAR in Million2SAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,111 1,340 1,579 1,804 1,416 1,092
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 5.223 x 8.432 x 8.24 x 9.732 x 6.517 x 3.062 x
Free Cash Flow 1 -191 -219 -223 -139 444 310
ROE (net income / shareholders' equity) 7.69% 2.16% 4.69% 4.32% 4.92% 10.6%
ROA (Net income/ Total Assets) 2.94% 1.73% 1.94% 1.88% 2.38% 4.13%
Assets 1 3,912 1,903 3,812 3,696 3,367 4,431
Book Value Per Share 2 1.810 1.940 1.930 1.920 1.970 2.140
Cash Flow per Share 2 0.0800 0.1100 0.1800 0.1200 0.1100 0.1600
Capex 1 89.7 161 272 202 128 71.6
Capex / Sales 3.04% 5.47% 8.22% 5.92% 3.47% 1.47%
Announcement Date 3/31/19 3/31/20 3/31/21 3/24/22 3/23/23 3/17/24
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
SAUDI CHEMICAL HOLDING COMPANY Stock Saudi Chemical Holding Company
+79.86% 1.75B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-31.79% 15.12B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-21.99% 12.26B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-22.64% 6.75B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6.13B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.91% 6.03B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.58% 4.78B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+59.24% 4.39B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-9.00% 3.76B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.43B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 2230 Stock
  4. Financials Saudi Chemical Holding Company